“…In their study of massive macrocystic lymphatic malformations, Chen et al observed excellent outcomes with a combination of fibrin glue, OK-432 and bleomycin in 53% of patients, in comparison to good and partial outcomes in 33% and 13% of cases, respectively. 19 None of the patients required surgical excision. 19 Thyroglossal duct cysts account for 70% of congenital neck masses; these lesions have a bimodal age distribution in which 90% of patients present by the age of 10 years, with a second peak in young adulthood.…”
Section: Discussionmentioning
confidence: 99%
“…19 None of the patients required surgical excision. 19 Thyroglossal duct cysts account for 70% of congenital neck masses; these lesions have a bimodal age distribution in which 90% of patients present by the age of 10 years, with a second peak in young adulthood. 4 Surgery in the form of a classic Sistrunk procedure is the preferred method of management.…”
Head and neck masses can present in different pathologies that usually vary according to the age of the patient. We report five cases of benign head or neck masses occurring among patients of different ages who were managed at the Bahrain Defence Force Royal Medical Services Hospital, Ar-Rifaa, Bahrain, between 2005-2014. All of the patients were treated using the sclerotherapeutic agent OK-432. Although surgical removal is usually considered optimal treatment in the management of such cases, OK-432 appears to be a promising alternative.
“…In their study of massive macrocystic lymphatic malformations, Chen et al observed excellent outcomes with a combination of fibrin glue, OK-432 and bleomycin in 53% of patients, in comparison to good and partial outcomes in 33% and 13% of cases, respectively. 19 None of the patients required surgical excision. 19 Thyroglossal duct cysts account for 70% of congenital neck masses; these lesions have a bimodal age distribution in which 90% of patients present by the age of 10 years, with a second peak in young adulthood.…”
Section: Discussionmentioning
confidence: 99%
“…19 None of the patients required surgical excision. 19 Thyroglossal duct cysts account for 70% of congenital neck masses; these lesions have a bimodal age distribution in which 90% of patients present by the age of 10 years, with a second peak in young adulthood. 4 Surgery in the form of a classic Sistrunk procedure is the preferred method of management.…”
Head and neck masses can present in different pathologies that usually vary according to the age of the patient. We report five cases of benign head or neck masses occurring among patients of different ages who were managed at the Bahrain Defence Force Royal Medical Services Hospital, Ar-Rifaa, Bahrain, between 2005-2014. All of the patients were treated using the sclerotherapeutic agent OK-432. Although surgical removal is usually considered optimal treatment in the management of such cases, OK-432 appears to be a promising alternative.
“…Bleomycin, a glucopeptide produced by Streptomyces Verticilus, which acts by breaking DNA chains with free radicals, affects tumor cells. Its side effects are erythema, edema, pain, local necrosis and flagellate hyperpigmentation (resolves with drug interruption) 14 .…”
“…Combined aspiration and compression is not always an effective treatment for the high rate of recurrence. Sclerosant agents cause fibrosis and obliteration of both lymphocele and ruptured lymphatic vessel, damaging the lymphatic drainage. The same side effect happens when performing macroscopic ligation of subcutaneous tissue containing lymphatic vessels.…”
Section: Discussionmentioning
confidence: 99%
“…Even sclerotherapy has been proposed and since Teruel reported first succesful case, employing povidone iodine for lymphocele, a lot of sclerosant agents have been used, mainly for pelvic, but even for subcutaneous lymphocele, such as bleomycin, OK‐432, polidocanol, sodium tetradecyl solfato, sodio azetroato, fibrin glue, etanol, and tetracicline. This therapy has the advantage of being very simple but the drawback is that these agents act by strong inflammation of lymphocele walls and lymphatic vessel, causing fibrosis and obliteration of both . Surgical treatment can consist in reexploration of the lymphocele and ligation of subcutaneous tissue where lymphatic vessels are presumed to be, without direct microscopic visualization.…”
Postsurgical subcutaneous lymphocele is caused by accidental lesion of a lymphatic vessel that keeps on flowing lymph under the scar. Traditional treatments include aspiration and compression, with probable recurrence, and sclerotherapy which destroys both lymphatic cyst and vessel, creating risk of lymphedema. We describe the case of a postsurgical subcutaneous lymphocele of the left leg that was treated by supramicrosurgical lympatic-venous anastomosis. A single anastomosis was performed end-to-end, between one lymphatic vessel, individuated through indocyanine green lymphography, and one subcutaneous vein, distally to the lymphocele, under sedation and local anesthesia. Postoperative course was uneventful; the lymphocele completely resolved and never recurred during the nine months followup. This technique may heal the lymphocele with no impairing of lymph drainage function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.